- completedPhase II
A research study testing NGM120 in pregnant women with severe nausea and vomiting (Hyperemesis Gravidarum)
This study tests a new medicine called NGM120 for women with hyperemesis gravidarum (HG), a severe form of pregnancy sickness. Researchers want to see if NGM120 safely reduces severe vomiting and nausea alongside standard care. Women aged 18 to 45 between 9 and 16 weeks pregnant may be eligible.
United Kingdom · England · Australia - recruitingNA
Randomized Study of a Dematerialized Management for Post-Emergency Gynecological Follow-Up
This study looks at whether using a health app for follow-up after a gynaecological emergency at home is as good as, or better than, going to the hospital in person. It aims to see if patients are happier with app-based care.
France